Application 761102
- Type
- BLA
- Sponsor
- SERVIER PHARMA LLC
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761102 | Asparlas | calaspargase pegol-mknl | 351(a) | Rx | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ASPARLAS | CALASPARGASE PEGOL-MKNL | INJECTABLE;INTRAVENOUS | 3750UNITS/5ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| asparlas | CALASPARGASE PEGOL | Servier Pharmaceuticals LLC | 6585bd0d-bd78-4341-9e87-0f7664821f05 | 2024-10-08 | Warnings, Adverse reactions | BLA761102 72694-515 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72694-515 | asparlas | calaspargase pegol | Servier Pharmaceuticals LLC | BLA | Current |
| 72694-515 | asparlas | calaspargase pegol | Servier Pharmaceuticals LLC | BLA | Current |
| 72694-515 | asparlas | calaspargase pegol | Servier Pharmaceuticals LLC | BLA | Current |
| 72694-515 | asparlas | calaspargase pegol | Servier Pharmaceuticals LLC | BLA | Current |
| 72694-515 | asparlas | calaspargase pegol | Servier Pharmaceuticals LLC | BLA | Current |
| 72694-515 | asparlas | calaspargase pegol | Servier Pharmaceuticals LLC | BLA | Current |
| 72694-515 | asparlas | calaspargase pegol | Servier Pharmaceuticals LLC | BLA | Current |
| 72694-515 | asparlas | calaspargase pegol | Servier Pharmaceuticals LLC | BLA | Current |